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This paper focuses on the longitudinal development of the glaucoma medical specialty 
with a view to capture the configurations of division of labor that contributed to or 
followed from novel understanding of the disease. The historical background is 
corroborated by an analysis of collaborative scholarly research over the period 1973-
2003 to illustrate how successive clinical and scientific modalities co-existed and 





The notion of innovation in medicine is almost mechanically associated to a battery of 
drugs and diagnostic tools that are employed for diagnostic, therapeutic, preventive, or 
experimental purposes. A number of scholars however remind us that health 
technologies are embedded in socio-economic contexts and that the ability to provide 
new or improved health-care services to the population depends crucially on 
organizational, entrepreneurial and institutional, other than technical, factors (Blume, 
1992; Henderson, 1994; Gelijns el al, 2001; Rosenberg, 2009). The latter remark 
resonates squarely with the broader tenet of innovation studies whose core goal is 
understanding the conditions which best facilitate the accumulation and the diffusion of 
knowledge, and its application into a variety of contexts of use (David, 1975; 
Rosenberg, 1976; Nelson and Winter, 1977; Metcalfe, 1998; Antonelli, 2008). In this 
body of scholarly work technology is portrayed as synthesis between a body of 
understanding and a set of codified routines that guide the associated activities. Inherent 
in this approach is also the uncertainty that permeates the endeavor of both cognitive 
and practical discovery: borrowing from Metcalfe (2010), innovation scholars portray 
technology as inseparable from the limitations of human agency. 
The recent spur of scholarly work on medical innovation (reviewed by Consoli and 
Mina, 2009) draws important insights also from the history of engineering, especially 
works by Constant (1980) on the turbine power and by Vincenti (1993) on aeronautics 
design. The appealing concept therein is that of an autonomous engineering 
epistemology, that is, of a body of technical knowledge not subservient or derivative of 
science but organized according to its own dynamics, principally that of problem-
solving. Nelson (2003; with Gelijns, 2010) transliterates these concepts into the realm 
of medicine by arguing that traditional scientific inquire on biochemical processes 
offers no more than a point of reference for medical research, and that the route through 
to workable solutions relies mostly on the development of capabilities to testing, 
implementing and diffusing novel diagnostic and therapeutic techniques. In this view 
scientific instrumentation has a central role in that it enables replicable experimentation 
thus guiding emergent modalities of inquiry (De Solla Price, 1984; Rosenberg, 1992; 
Gelijns and Rosenberg, 1994). This strand of research marks a significant point of 
discontinuity with the traditional literature on health technology diffusion by arguing 
that successful clinical modalities are independent from advances on basic scientific 
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understanding concerning the nature and the causes of disease (Nelson, 2003; 2008; 
Nightingale, 2004). 
A central ingredient in the study of medical innovation pace Nelson and fellow 
innovation scholars is the appreciation of problem-solving as engine of knowledge 
growth. Paraphrasing Simon (1969), problem-solving in medicine entails pursuing 
clearly defined goals (e.g. cure or prevent illness) through routes that Dosi and Egidi 
(1991) would call ‘procedurally uncertain’. In this framework the nature of the problem, 
or better the assortment of problem typologies, shapes the task structure, that is, the 
clinical modalities toward which efforts are directed (Elstein et al, 1978). But problem-
solving is also multi-dimensional whereby as some problems are solved others range 
into view and become new foci of innovative efforts within the broad objective to 
improve the efficacy of the overarching procedure. Advances in medical know-how 
involve hierarchic search whereby meta-problems (e.g. heart failure, blindness) set the 
broad goal and channel subsequent efforts in search of a solution and, possibly but not 
imperatively, an explanation on disease. To operationalise this concept we propose that 
the medical problem-solving heuristic involves the definition of meta-hypotheses, or 
working frameworks, that circumscribe the broad operative principles of the disease 
area at hand.1 The history of medicine shows that search processes within such meta-
spaces likely generates multiple sub-hypotheses, some contradicting some 
complementing each other, some stemming as articulation of specific features within the 
broader model others speculating on observations that do not fit within the prevailing 
meta-hypothesis. It is not infrequent that sub-hypotheses develop into meta-hypotheses 
once demonstrated that perceived irregularities fit into a coherent revision of disease 
(Rosenberg, 1990). Because ex-post selection among different paradigms is a lengthy 
process hypotheses and styles of practice tend to co-exist over periods before some are 
discarded off in the long-run, or before two hypotheses are merged into one (Elstein et 
al, 1978). 
Given the multiplicity of dimensions that are involved problem-solving entails the 
interaction of heterogeneous knowledge bases. Commenting on this, Consoli and Mina 
(2009) propose the notion of Health Innovation Systems (HIS) as framework to 
articulate the technical, institutional and organizational gradients of medical innovation. 
Such systems are dynamic constructs comprising of gateways, that is, constellations of 
component organizations engaging health-related activities, and pathways, that is, 
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mechanisms aimed at the coordination of the ecologies of competences across five 
dimensions2 : (i) the body of knowledge that makes up scientific understanding of 
disease; (ii) the set of clinical practices that support the design of diagnostic and 
therapeutic interventions; (iii) the organization of industry that determines the ability to 
produce and supply the proposed interventions; (iv) the institutional set-up for the 
provision of Health-Care services to the population; (v) the instituted channels for 
assessing the effectiveness of patient care, and for receiving and processing the 
feedback stemming from the front-end. The key proviso is that the translation of novelty 
into the clinical realm is contingent on complementary adaptations in the other 
component domains3.  
It goes without saying that in their continuous evolution Health Innovation Systems 
generate configurations of division of labor across foci of basic and applied research 
such as university departments, research laboratories, units for delivery of health-care 
services, firms as well as hybrid types like university hospitals. The present paper 
focuses on this particular aspect and details patterns of inter-organizational 
collaborations underpinning the long-term evolution of a medical specialty. 
Methodologically the paper differs from other studies on medical innovation in not 
recounting the ‘career’ of any specific technology (see Blume, 1992) but rather in trying 
to capture the changing boundaries of a medical discipline as successive clinical and 
scientific modalities co-exist and influence each other (Pickstone, 1993). In so doing we 
focus on interconnected dimensions of medical problem-solving, namely: the changing 
sets of skills that define the glaucoma specialist profession over time; the loci of 
scientific collaboration that have stirred new clinical practice and new medical 
understanding; and, the technological complex that has emerged both as a response or 
as a stimulus to shifting perceptions of disease. None of these taken in isolation would 
suffice to account for the long-term evolution of the discipline. 
The paper is structured as follows. Section 2 introduces the long-term developments of 
the medical glaucoma specialty. Section 3 discusses the rationale for the growth of 
research collaboration in general, and the growing importance of division of scientific 
labor between academic and non-academic organizations. The empirical analysis is 






Glaucoma is a family of chronic diseases due to the degeneration of the optic nerve; its 
onset is asymptomatic in early stages and leads to blindness if untreated. It is the second 
most common cause of blindness worldwide (Tylefors et al, 1995) with an estimated 
global incidence of about 67 million (Source: AHAF) 4. The causes behind glaucoma 
and the way in which it leads to loss of sight have not been clearly identified; 
glaucomatous damage can be slowed down but not reversed, and no specific preventive 
measures exist. To date the most significant areas of improvements concerns the 
classification of different forms of the disease as well as refining surgical and 
pharmacological interventions for very specific ends. Glaucoma makes an interesting 
case study in that the persistence of a particular framing – which is now unanimously 
judged by the ophthalmology medical community as ‘only partially’ correct – has been 
at root of much misdiagnosis and partly ineffective clinical response. The following 
subsections elaborate a stylized synthesis of the key milestones and of the background 
conditions that triggered or thwarted progress in this area. Table 1 will be used as 
guiding reference for this historical journey, and serves not merely as recollection of 
events but rather as stylized summary of the two-way interdependence between 
scientific and clinical knowledge. 
TABLE ONE ABOUT HERE 
1854-1951: Although the practice of eye surgery goes back to India in the 5th century 
B.C., ophthalmology became established as medical specialty in Wien only in the mid-
19th century (Kansupada and Sassani, 1997). Glaucoma practice moved his first 
important steps thanks to the pioneering work of Albert von Graefe, an eye surgeon who 
in the mid 1800s reported about the beneficial effects of the then experimental surgical 
practice called iridetcomy, an eye incision which would became standard procedure in 
following years. A series of further experimentations of this kind contributed to the 
notion that excess Intra Ocular Pressure (IOP) of the aqueous humor was the main cause 
of the typical congestion of glaucomatous eyes, and that surgery could provide relief by 
unblocking the flow (Hulke, 1859). Before the invention of specialist tools, 
ophthalmologists checked ocular tension by digital palpation of the eye and inspected 
the fundus of the eye with a slit lamp and a lens through atropine-dilated pupil.  
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Back in the days of Von Graefe and until the end of the XIX Century ophthalmology 
was the province of surgeons who would approach clinical cases in trial-and-error 
fashion with minimal linkages between bedside and bench. As a matter of fact until the 
early 1950s both in America and elsewhere ophthalmology was taught as a part of the 
basic medical curriculum due to overall low prospects of specializing in what was 
considered an incurable disease (Liesegang et al, 2003). Moreover despite the American 
Ophthalmological Society being operative in 1864 as the first medical specialty 
organization in the US, no specialized scientific outlet existed besides the Acta of the 
Society’s meetings (Newell, 1997). In this context the assimilation of glaucoma to 
hydraulic blockage and the association of its cause with the most observable symptom, 
excess pressure, became the guiding operational principle throughout the first half of 
1900. This is a clear instance of how truth-to-nature observation (Daston and Gallison, 
2007) of symptomatic evidence paves the way to a model of understanding a particular 
phenomenology in the absence of – or inability to perceive – contrary evidence. 
The absence of a proper scientific infrastructure however was no obstacle for individual 
practitioners who developed a variety of scientific instruments consistent with the 
direction indicated by Von Graefe. A state-of-the-art glaucoma test at the turn of the 
century consisted in the combined use of a tonometer to measure IOP, an 
ophthalmoscope to scrutinize the fundus of the eye, and a gonioscope to assess the iris 
angle. Clearly the style of practice was adapted to the perceived nature of the problem 
as no single tool within this battery would suffice to detect this elusive disease. The 
instruments also shaped the skills that were used by and taught to trainees, such as 
criteria for judging eye appearance and for performing surgical incisions; making 
records of clinical observations on the other hand was not widespread practice yet. In 
the following years these modalities would contribute to disclose remarkable 
irregularities across different forms of glaucoma, in its symptomatology and incidence 
across patients; this evidence, once combined together systematically, would usher a 
new scientific era for this area of medical practice. 
1952-1970: the beginning of the second phase in the history of glaucoma research is 
marked by the first International Symposium on glaucoma in 1952. By bringing 
together for the first time practitioners from all over the world the event reaffirmed the 
collective identity of this dispersed community and promoted glaucoma to independent 
sub-specialty within the broad realm of ophthalmology. The symposium represents a 
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noticeable point of discontinuity for the system of thinking of the ophthalmologic 
community because the articulated summary of different disease manifestations was 
tangible proof that the extent of its diversity was greater than had hitherto been 
appreciated. One of the key outcomes was the first international classification of 
glaucomas obtained by collating and comparing systematically evidence from different 
sources for the first time (Duke-Elder, 1955). As Table 1 shows from this point onwards 
glaucoma will no longer be considered a single disease but rather a family of eye 
conditions; a direct consequence of this was the partitioning of the glaucoma meta-
problem into various sub-domains according to the established typologies and the 
associated modalities of research and practice. 
At a more fundamental level the newly accepted heterogeneity of the disease raised 
doubts on the foundations of the IOP paradigm. This is confirmed by a stream of 
epidemiological studies aimed at testing the (hitherto granted) co-occurrence between 
ocular pressure and glaucoma. Following the pioneering steps of Hollows and Graham 
(1966) such studies demonstrated that IOP is only a risk factor, and that only about 10% 
of people with increased abnormal pressure are affected while about 25% of glaucoma 
patients have normal pressure levels (see Liesegang, 1996). These groundbreaking 
discoveries added substantive uncertainty concerning the aetiology of the disease and 
caused a stall within the medical scientific throughout the 1960s (Consoli and 
Ramlogan, 2008). Accordingly the standard ophthalmologic practices for glaucoma 
testing and therapy did not change much in this period except for the addition of 
perimetry, a technique to assess visual field based on direct collaboration between 
clinician and patient who is asked to report the detection of visual stimuli. Likewise 
little changed on the surgical front besides the emergence of the novel technique of 
implanting tubes in the eye to drain excess liquid. Overall, it seems safe to conclude that 
by the end of this second phase the glaucoma specialty had not changed much compared 
to the previous phase if not for deepening of the characteristics that shaped already 
existing therapeutic and diagnostic modalities. 
1971-1991: Glaucoma research and practice enters a new era in the 1970s, propelled as 
it was by a spur of new ideas and ever more specialized conjectures inspired from 
clinical, epidemiologic and laboratory research (see Table 1). The accepted diversity of 
the disease prompted efforts aimed at perfecting the classification of glaucoma, thus 
paving the way to a variety of research directions. One approach set out to explore 
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associations between glaucoma with other diseases, especially diabetes and heart 
conditions, in search of regularities that could elucidate on the aetiology. Another 
important branch of research stemmed from the rediscovery of intuitions that had been 
recorded back in the old days but that remained overseen or not understood properly; 
most prominent among these are the remarks made by von Graefe (1857) about the 
recurrence of an excavation in the optic nerve of a glaucomatous eye. This particular 
feature, which in modern jargon is known as ‘cupping’, became the focus of much 
attention and the key to fundamental developments between the mid 1960s and the late 
1970s. As the incidence of IOP was downsized to risk factor practitioners who engaged 
also research focused on the linkages between eye pressure and damage in the optic 
nerve. This meta-hypothesis was articulated in two main directions: the mechanical 
theory had it that intraocular pressure exerts a force that compresses the optic nerve thus 
altering its functionality; the vascular theory conversely posited that high pressure 
damages the optic nerve by reducing the nourishment of blood supply. It is now 
accepted that neither theory explains how optic nerve damage occurs across different 
types of glaucoma, and that the effects described by either probably work in 
combination rather than being mutually exclusive (Geijssen, 1991).  Table 1 reports also 
about two nascent research strands which would later lay the ground for biological and 
genetic approaches to glaucoma. 
The proliferation of hypotheses concerning the aetiology coincides with the emergence 
of new instrumentation and pari passu advances in digital imaging, laser and ultrasound 
general-purpose techniques (Blume, 1992; Geljins and Rosenberg, 1999). In the second 
half of the 1970s US researchers discovered a correlation between the erosion of the 
optic nerve cum glaucoma and visual field loss; this contributed enormously to shift the 
reference model from hydraulic blockage to neuropathy (Drance, 1975). Accordingly 
IOP measurement progressively made room to alternative techniques such as 
assessment of eye structure (optic nerve) and of its functionality (visual field). This 
induced, first, the adoption of digital photography for qualitative assessment of the optic 
nerve and later of the scanning laser ophthalmoscope for quantitative assessment 
(Quigley, 1998; Sharp et al, 2004). At a more fundamental level embracement of 
indirect observation mediated by the technological devices underscores the evolving 
logic of diagnostics since glaucoma was no longer understood as a ‘binary’ but rather as 
progressive disease; one in which chances of detection and of effective treatment 
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depended on the stage of the neuropathy; one in which, furthermore, the boundaries of 
clinical practice drifted in pursuit of the ‘mechanical objectivity’ (Daston and Gallison, 
2007) promised by improved techniques for visual reproduction. 
In this eventful phase the skill base of glaucoma specialists expanded to facilitate 
interaction with formerly unrelated areas of science; as Ramlogan and Consoli (2007) 
show, the universe of scholarly research on glaucoma mushroomed in journals on 
neurology, cellular biology and genetics after the mid-1990s. For what concerns the 
therapeutic front, in the mid-1980s Beta-Blockers become the drug of choice for 
patients with IOP-related glaucoma (Rafuse, 2003). 
1992-2003: in the last phase of our stylized summary glaucoma research reaches out 
towards new shores such as genetics, cellular biology and molecular science. The onset 
of this was the discovery that glaucoma incidence varies significantly according to age, 
racial background, and family history; in short, that glaucoma is a demographically 
selective disease (Wadhwa and Higginbotham, 2005). This issue carries obvious 
political and institutional implications concerning accessibility of health-care both 
across and within countries, especially those with high ethnic mixes. The other relevant 
finding, that glaucoma tends to run in families, laid the ground for the discovery of the 
gene responsible for Primary Open Angle Glaucoma in the 1990s (Stone et al, 1997). 
Initial enthusiasms however dwindled as soon as it became clear that only 3% of cases 
are associated to defects in single genes, and that no single mode of inheritance 
adequately describes the disease. It seems that glaucoma depends not so much on a 
single gene but rather upon the interaction of several in combination with environmental 
factors (Wiggs, 2007). This is to say that despite remarkable progress in scientific 
understanding, translational gaps hold at bay improvements in practice and that the 
scenario of routine genetic screening remains remote. 
Another important thread in glaucoma research follows on the path set by neuropathy 
studies back in the mid 1970s, in particular the discovery of erosion in the optic nerve 
fibers due to glaucomatous damage (Hoyt et al, 1973). The emergent diagnostic 
modality has progressively shifted from direct observation of the optic nerve to 
computerized assessments of the thickness of the optic nerve fibers (Retinal Nerve Fiber 
Layer, RFNL) (Sommer et al, 1984). In this new regime technologies such as Scanning 
Laser Polarimetry (by Laser Diagnostic Technologies, Inc.), Laser Retina Tomography 
(by Heidelberg Engineering, Inc.) and the Optical Coherence Tomography based on 
INGENIO (CSIC‐UPV) Working Paper Series 2010/06 
10 
ultrasound (Zeiss-Meditec, Inc.) are used to produce quantitative measures of optic disc 
structure and nerve consistency and calculate indices for monitoring morphologic 
change due to disease progression over time (Schuman and Lemij, 2000). It is worth 
stressing that these forms of computerized assessments carry both benefits as well as 
problems; some of these are technical: for example, computerized data collection makes 
sense within a regime of longitudinal testing to detect disease progression in individual 
patients, but this particular task requires data handling skills from humans as well as 
compatibility across data collected at different points in time and, given the rapid pace 
of technical advance, by presumably different devices (Trick et al, 2006). Parallel to this 
stand concerns among ophthalmologists who seek to reaffirm the value of ‘trained 
judgment’ (Daston and Gallison, 2007) as dominant scientific style in which 
sophisticated artifacts capture but don’t discern meaningfully patterns.5 
The preceding observations underscore significant transformations in the skill base of 
glaucoma specialists, whose modern version is far removed from the eye surgeons of a 
century ago. Glaucoma specialists work in teams where traditional medical skills blend 
with interpersonal communication skills to engage both co-workers (ophthalmic nurses, 
optometrists, clinic managers, etc) and patients; in fact since age is a significant risk 
factor for increased ocular pressure, ageing populations account for progressively higher 
demand for eye treatment as well as long-term disease management skills as opposed to 
one-off interventions. 
This phase marks also a divergence between diagnostic and therapeutic paradigms. For 
what concerns the drugs, despite well-reported failures beta-blockers are still the first 
therapy of choice for glaucoma (Rafuse, 2003); evidence about the associated side 
effects has ignited the search for alternative drugs which could target the specific 
features of the various forms of glaucoma that have been unveiled over the years. In the 
absence of a magic bullet even for IOP-related cases the most common solution in 
recent years has become the prescription of combined eye drops. To conclude, it is 
worth highlighting further recent enrichments of the educational matrix with the 
separation of medical ophthalmology (a range of laboratory activities for the study of 
specific eye diseases like glaucoma) from the general curriculum, as well as the 




3 Patterns  of  intra­  and  inter­organizational 
collaboration 
The preceding sections illustrate that progress in clinical and scientific know-how on 
glaucoma has unfolded in additive fashion stirred by complementary meta-hypotheses 
and the emergence of associated modalities for diagnosis and treatment. That these 
changing knowledge structures are embedded in changing configurations of division of 
labor is a reasonable but still implicit assumption; in this section we seek to address the 
matter more explicitly. Before delving into the data it is important to remind briefly 
what an analysis of collaborative patterns adds to the broader endeavor of studying 
medical innovation. An important qualification of the evolutionary view of medical 
know-how discussed before is that the repertoire of activities and the skills embodied 
adapt to the task structure as the problem is analyzed and solutions are tested. The 
matrix of knowledge generating activities is therefore embedded in the institutional 
contexts from which it stems and whose direction it shapes in its further evolution; 
accordingly, the structure of activities that are needed for practical problem-solving 
embodies, albeit imperfectly, the kinds of organizations that partake this endeavor. 
This paper focuses on collaborative research arrangements between organizations aimed 
at pooling resources for the development of new scientific knowledge (Hagedoorn et al., 
2000; Ponds, 2009). Growing empirical evidence on research collaboration has attracted 
much attention recently (Katz and Martin, 1997; Wagner-Doebler 2001; Porter and 
Rafols, 2009). As a matter of fact increasing scale and heterogeneity of scientific 
collaboration fueled emergent approaches on new modes of knowledge production 
(Gibbons et al. 1994) and on the Triple-Helix model of interactions among academia, 
business firms and governmental organizations (Etzkowitz and Leydesdorff, 2000). In a 
nutshell the rationale for collaborative research can be articulated as follows: cost 
advantages due to the opportunity of pooling resources; economies of scope spurred on 
by the proliferation of new and ever-more specialized scientific fields and subfields; 
third, and related, the necessity to develop specialized expertise in the use of complex 
scientific instrumentation. 
Propensity to collaborate entails important implications for the division of scientific 
labor. The common argument is that individual organizations, or organizations of a 
specific type, are generally unable to keep up with the increasing complexity of the 
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attendant scientific fields. Research in the context of science-based industries 
emphasizes the growing importance of non-academic organizations in collaborative 
scientific research, and the emergence of inter-organizational networks as key locus of 
innovation (see Gambardella, 1995; Powell et al., 1996; Orsenigo et al, 2002; Orsenigo 
et al, 1997; Owen-Smith et al, 2002). Likewise, the matrix of knowledge generating 
activities in the field of medicine typically involves interactions across university 
departments, centers for health-care delivery and firms. Understanding the division of 
epistemic labor across these requires an appreciation of the nature of coordination 
between engineering science and technology, clinical science, biomedical science and 
medical practice. More than this, the key issue is accounting for how the evolution of 
knowledge and technology bear upon the division of labor across different types of 
organization. 
To date only a handful of works have set out to address explicitly the changing 
configurations of division of labor underpinning medical research. Gelijns and 
Rosenberg (1999) detail the interaction between medical school clinicians and 
producers of health devices in shaping the industry of diagnostic tools. Subsequently 
Gelijns and Thier (2002) appreciate the extent to which universities’ endowment of 
research tools and capabilities complements both traditional industry assets for 
undertaking research and development as well as clinical activities stemming from 
direct interaction with patients on the bedside; the thrust of this triangulation of 
expertise, it is argued, are feedbacks that accelerate knowledge generation, open up new 
opportunities for learning as well as fostering effective development of new 
technologies. In a recent appraisal of the long-term evolution of Life Sciences, 
Rosenberg (2009) reiterates that much progress is due to breaking down of 
interdisciplinary and inter-organizational barriers and the associated dynamics at the 
interface of scientific research and new product development.  
Following up these authoritative antecedents the remainder of the paper investigates 
patterns of intra- and inter-organizational division of labor underpinning medical know-
how on glaucoma, and addresses the following questions: which types of organizations 
become involved? How does their contribution change over time? And, does any 





Our review of collaborative scholarly work in the area of glaucoma combines primary 
sources, scientific articles, with secondary ones like formal summaries of the literature 
that aided the identification and classification of the published material. A short proviso 
is in order. Scholarly co-authorship evidences direct and intentional association between 
two or more (or groups of) authors; repeated observation of such interactions over time 
speaks to the organizational dynamics underpinning evolving scientific expertise 
(Orsenigo et al, 1997). Co-publications are frequently used as indicators of collaborative 
scientific research, sometimes inappropriately, as Katz and Martin (1997) warn; 
Lundberg et al. (2006) argue however that longitudinal analysis of co-authorship is a 
valid indicator for the type of task we set out to explore. 
We consulted the ISI Thompson database for articles containing ‘glaucoma’ in the 
Topic field – which includes title, keywords and abstract. The initial search returned 
13164 papers over the period 1945-2003 but since information is more detailed for 
scholarly work published in the 1970s and onwards, and since the phenomenon we are 
mostly interested in – multiple authorship – took off in the same period, we narrow the 
sample to 9361 papers published between 1973 and 2003. This was subdivided into 
1599 ‘single author’ and 7832 ‘multiple authors’ articles and, using the institutional 
addresses of the authors as a guide, the latter further partitioned into Intra-
organizational collaborations (papers co-authored by two or more individuals based in 
the same type of organization) and Inter-organizational collaborations (two or more 
individuals based in different types of organizations). Table 2 shows the cumulated 
frequencies of each of these categories across decades. 
TABLE TWO ABOUT HERE 
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To discern meaningful patterns within these data all collaborative scholarly work was 
assigned to one of the following categories depending on the type of organization to 
which authors are affiliated: Research Units (RU) comprising universities and public 
research laboratories; Health-Care delivering Units (HC) comprise hospitals, clinics and 
medical centers; and Firms (FRM). The shares of collaborative research across the 
period displayed in Diagram 1 shows that after initial predominance of intra-
organizational research (e.g. within HC and within RU) inter-organizational research 
grows from the early 1990s onwards; while the combination Research Units and 
Hospital type of organizations (RU-HC) has a relatively high presence throughout, in 
the late period firms’ contribution increases as diagnostic technologies are integrated in 
the clinical modalities (see preceding section). 
FIGURE ONE ABOUT HERE 
Observing the ecology of organizational types carrying out scholarly work on glaucoma 
begs the question of who worked on what. Though it is hard to establish direct causality 
one may speculate that high level of co-specialization between objects and procedures of 
search reinforces complementarities and feedbacks in the organization of research 
activities (Powell et al, 1996; Orsenigo et al, 1997). Consistent with the initial idea that 
the nature of the problem dictates the problem-solving strategy (Simon, 1969) we 
expect to be able to make sense of correspondences between changing configurations of 
the division of labor associated to different clinical and therapeutic modalities vis-à-vis 
the historical backdrop outlined above. To address this matter we classified the papers 
according to research area by reading through all abstracts to assess the object of 
analysis and the method of investigation;6 the screening produced a list of 26 topics 
divided in 5 macro-areas (see Tables 3-5 for details and the Appendix for a description). 
After having provided each paper with a unique ‘topic identifier’ we cross-tabulate 
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these data with those on the collaboration types: Tables 3-5 provide a snapshot of the 
whole period 1973-2003 and of the two historical periods 1973-1990 and 1991-2003 
discussed in the preceding section. 
TABLES THREE, FOUR, FIVE ABOUT HERE 
A look at the topics distribution in Table 3 shows that between 1973 and 2003 the 
macro-area of Diagnostics holds the lion share (35%) with leading topics such as Eye 
Structure and Neuropathy, overall consistent with the paradigmatic shift of glaucoma as 
progressive disease discussed earlier. Research on Therapy (second highest, 27%) 
confirms the prominence throughout the periods of clinical work carried out to develop 
or improve existing modalities based on surgery, drugs as well as Disease Management. 
The third most voluminous macro-area of scholarly research (18%) is on Experimental 
areas like Laboratory work, Genetics and Cellular Biology. By and large these raw 
numbers confirm the orientation outlined in the historical background. 
Let us now break data longitudinally across two sub-periods 1973-1990 and 1991-2003 
(Tables 4 and 5) and focus on topics rather than macro-areas. The Spearman rank-
correlation test (rs=0.102; p-value=0.619) offers a first hint at how research efforts 
distribute over time, and indicates that the priority of glaucoma research changed over 
time. A closer look at the data in fact suggests that on the one hand research on 
association with other diseases and assessment of changes in eye structure remain 
relevant throughout; on the other hand Laser Diagnostics, Cellular Biology, IOP and 
Drugs become relatively more popular to the detriment of Glaucoma classification, 
Vascular causes and Visual-Field Assessment. Further, we cross-analyze data to 
appreciate what configurations of division of labor emerge in the sample under analysis. 
The chi-square test (p>0.001) rejects the null hypothesis that the distributions of macro-
areas and of organizational types in Table 3 (RU, HC, etc) are independent. A cursory 
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look at these frequencies confirms what anticipated by Figure 1 namely that in the 
aggregate the bulk of research was carried out either in the clinical setting (HC), or at 
the interface between the latter and traditional research organizations (RU-HC); but 
Figure 1 shows also that cross-organizational research has become more diverse in the 
latter part of the period due to the growing involvement of firms in areas like drug 
development and diagnostic machinery. 
To gain a more precise idea of the patterns of scientific specialization we use 
correspondence analysis, which is apt for graphical representations of multi-way 
categorical data (see Greenacre, 1984; 1993). The position of each element in a graph is 
the translation of quantitative relationships in spatial terms on a chi-squared metric (as 
opposed to Euclidean) space; in the resulting graph closer-to-average categories are near 
the origin while more heterogeneous ones are on the periphery of the Figure, and the 
distances among points reflect differences in their organizational-scientific profiles.7 
Accordingly, the graphical output of Figures 2 and 3 plots the structure of relations 
between 6 organizational types (rhomboid shape) and 26 research topics (dots) 
respectively for 1973-1990 (Table 4) and 1991-2003 (Table 5). 
FIGURES TWO, THREE ABOUT HERE 
Let us look at the Figures individually. Around the origin of Figure 2 are the most 
prolific types of scholarly collaboration by volume of published work, namely HC, RU 
(both intra-organizational) and RU-HC (inter-organizational) while the remaining (e.g. 
RU-HC-FRM) are remotely positioned to the left of the origin. If a given type has a 
very specialized profile, that is, high concentration of research on one topic it will 
appear on the periphery of the map, like the case of firms (FRM) on Drug development 
(dot 25) or HC-FRM and RU-FRM on early Cellular Biology research (dot 9). The most 
prolific types at the centre of the Figure hold heterogeneous research portfolios as 
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confirmed by the clustering observed in proximity of the origin. Hospital-type 
organizations engage the whole therapeutic spectrum – except Drugs – (dots 21-24 and 
26), some diagnostic modalities (12, 15, 17) as well as Classificatory and Epidemiology 
research (1-2 and 4-5); the other cluster orbiting around RU and RU-HC types includes 
a mix of diagnostic work (Neuropathy: dot 11; Eye Structure: 20), basic research (e.g. 
Intra-Ocular Pressure: 6). Interestingly some topics for which there is no prominent 
assignment of research work, are centrally placed like Laboratory experiments (7) and 
Disease Management (26) which are equidistant from either of the main clusters. One 
last remark concerns research areas at an infant stage such as Imaging Diagnostic (13) 
or basic research on Diagnostic (14) (bottom of the Figure) and Ultrasound (16) (top), 
all peripherally located. 
Figure 3 for period 1991-2003 tells a different story. First of all, the core of the Figure is 
more populated due to the growing involvement of organizational types cum firms 
which were only peripheral in the preceding period; a second interesting feature is the 
lower dispersion of topics, dots in the graph. Combined together these indicate that this 
phase is characterized by clearer distribution of topics by type of collaboration and, 
thus, of division of labor. The top right quadrant is home to the largest inter-
organizational type, RU-HC, and includes clinical research on two peculiar forms of 
Glaucoma, Early (dot 2) and Low-Tension (4), studies on Eye Structure (20) and two 
diagnostic areas, Ultrasound (16) and Visual-Field (19). In general, Diagnostic 
technologies (dots 15-19) are mostly in the right hand side quadrants with the exception 
of Nerve Fiber Layer assessment (17). Research on Eye Structure (20) is equidistant 
from the two large intra-organizational types RU and HC, respectively in the top- left 
and bottom- left quadrants. Comparing these we note that the former is the locus of 
basic medical research on General Glaucoma (1), of Epidemiology studies (5 and 6), of 
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all Experimental work (7-10) and general research on Neuropathy (11); the bottom-left 
quadrant is that where Health-Care deliverers conduct clinical work on Acute Glaucoma 
(3) – which indeed requires urgent clinical treatment –, consolidated techniques 
involving Imaging technologies (16) or Nerve Fiber Assessment (17), all traditional 
surgery (22-24) and Disease Management (26). In the bottom-right quadrant is a mix of 
collaborative research involving Firms, specifically HC-FRM on laser diagnostic (15) 
and surgical (21) techniques, and RU-FRM on therapeutic research on IOP-lowering 
drugs (18 and 25). The most peripheral nodes, Firms alone or the mixed type RU-HC-
FRM contribute relatively less to collaborative scholarly research on glaucoma. 
Comparing Figures 2 and 3 suggests that diminishing dispersion together with 
redistribution of topics matches reasonably well the profile of the individual 
collaborations, for example Research Units mostly involved with basic research, as 
opposed to Health-Care deliverers with clinical research. Taken together these results 
lend support to the notion of division of (research) labor cum deeper specialization. The 
graphs also capture the maturation of diagnostic techniques from an experimental stage 
in the earlier period to being fully integrated in the clinical realm in the latter. In fact the 
aggregate picture of Table 3 conceals that clinical procedures that have always been in 
use, like Visual-Field Assessment or IOP-lowering drugs, are grouped together with 
modalities which have undergone an experimental phase during the time horizon under 
analysis – such as Laser Diagnostics or Laser Surgery. Another way of saying this is 
that without careful framing in the history of this discipline, data may actually conceal 
important aspects. Overall the dynamics extracted from the data fit the historical 
background outlined in the preceding section, in particular the schizophrenia of a 
discipline whose diagnostic know-how has reached a high degree of sophistication and 
of diversity opposed to a therapeutic menu still locked in the stone age of the old, and 
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proved to be incorrect, IOP paradigm (for a commentary on this see Quigley, 2004). 
While scholarly research has made much headway on the operative principle of how 
glaucoma works by shifting the model of reference from hydraulic blockage to 
progressive (Eye Structure) and multifactorial (Association) neurological disease, 
knowledge about the aetiology still looms in the dark, as confirmed by the recent spur 
of experimental research. All along this process, and coherent with Nelson´s chief 
argument, scientific knowledge did not precede experiential know-how, if not to 
mislead. Rather, it was informed by it. 
5 Concluding Remarks and Future Steps 
This paper has been concerned with shifts in the jurisdiction of the glaucoma medical 
specialty. The history of this disease is a prime example of how the efficacy of scientific 
conjectures and of diagnostic and therapeutic avenues has been severely biased by 
incorrect framing and the persistence of the latter in the clinical realm. It is worth 
concluding with some reflections as on what this analysis adds to the existing body of 
work on medical innovation. 
Let us suggest that, first, the paper reaffirms the dynamicity and uncertainty which 
Geljins et al (2001) hold at heart of the discovery process that enables improvements in 
diagnosing, healing and preventing human sickness. Transliterating Simon (1969) the 
search for solutions to medical problems is beset by substantive ignorance concerning 
the cause of disease as well as by procedural uncertainty as on how to tackle it. Progress 
in life sciences has gone through different regimes for organizing health-care. At heart 
of this process are the removal of cross-disciplinary barriers (Rosenberg, 2009) as well 
as the intensification of experimental regimes for manipulating, reproducing and 
evaluating physiological phenomena (Nelson, 2008; Nelson and Geljins, 2010). The 
correlation of these two forces, horizontal dynamism across disciplinary boundaries and 
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vertical transmissions between basic scientific and experiential realms, has provided a 
major step change in the production, diffusion and use of knowledge in medicine 
(Consoli and Mina, 2009). The history of glaucoma shows that the major breakthrough, 
the shift from hydraulic blockage to neurological paradigm, stemmed from the latter 
force, systematic organization of experiential observation, and developed further guided 
by the former, the abridging of ophthalmology with other specialties which were 
brought to matter. More than this, the changing configurations of division of labor 
associated to these driving forces speak to the importance of diversity not only of types 
of organizations involved but also of typologies of interaction generated in the context 
of their collaboration. In so doing the paper adds an organizational dimension to our 
previous studies on glaucoma research which focused on the population of authors 
(Consoli and Ramlogan, 2008) and of scientific journals (Ramlogan and Consoli, 2007). 
Another contribution of this paper is the extension of the remit of medical innovation 
beyond the limits explored so far. The history of diagnostic and therapeutic modalities 
for of glaucoma as well as the others mentioned here elucidate on the extent to which 
organizational configurations bring to bear on the effectiveness of experimental design. 
When successful, this translates into creating appropriate preconditions by activating the 
right mix of specialism and by designing regimes of ex-post transmission of newly 
acquired knowledge, namely clinical training. This is to suggest that the ‘career’ of 
individual technologies (see Blume, 1992) is underpinned by a wider universe, the 
medical discipline, which presents itself as the rightful phenomenon to observe. Medical 
discipline is both the game and the rules by which the game is played, in that it 
simultaneously organizes scientific knowledge and establishes parameters for the 
formation of scientific and professional settings, evidently involved with the 
specialization of work and division of knowledge. This resonates with Kuhn’s (1962) 
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view about the structural dependence of science in relation to teaching; teaching shapes 
both the users of knowledge and those who will directly contribute to scientific 
advancement. The history presented here offers an indication of the extent to which 
practice and training have been crucial to the generation and transmission of knowledge. 
Glaucoma is also an important reminder about the variety of models for innovation in 
medicine. The story recounted here is representative of a broad class of disciplines 
characterized by: limited understanding of the disease, which inhibits effective 
prevention; by some progress in the diagnostic realm where no dominant standard exist 
among clinical procedures; and by relative backwardness in the therapeutic front 
(existing drugs only cater for IOP-related cases). This combination of characteristics 
suggests an association between Glaucoma and some types of cancer (Pancreatic, 
Liver), while differing from other case studies where effective solutions and a good 
understanding of the aetiology have been achieved, like Cataract, Coronary Artery 
Disease, Orthopedic disk, L-VAD and Poliomyelitis. It is hoped that new empirical 
material will contribute to enrich both this notion of variety, and elucidate on the 
consequences for the organization of knowledge-generating activities. 
One last obligatory remark concerns the way ahead. The recurrent addition of new 
empirical work asserting the relevance of ‘other’ dimensions within the complex 
universe of health-care adds to the impression that the more we learn the longer 
becomes the path. This, in the spirit with which this paper was written, is true to the 
extent that human know-how is an open system and thus bound to continual 
reconfiguration, just as our own understanding of the phenomena we set out to analyze. 
In this paper we emphasize the importance of two dimensions: the shift of boundaries 
across professional domains to feed current knowledge, and the organization of training 
to preserve the latter and create future knowledge. Our future research will concentrate 
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on these two aspects, specifically: how the evolution of cross-disciplinary 
organizational settings impinges upon the matrix of medical-related activities; for what 
concerns the second issue we set out to investigate how medical curricula evolve in 
order to appreciate how the supply of skills adapts to the demand of ever more 
specialized activities. And, further down the line, we would seek to test systematically 
the extent to which medical disciplines develop in uneven fashion (Nelson, 2002). But 
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Table 1: long-term clinical and scientific developments in glaucoma 
 
 1854-1951 1952-1970 1971-1990 1991-2003 
Meta-hypothesis 
 
Intra Ocular Pressure    
Different types of glaucoma 
 
   Primary Open Angle Glaucoma 
   Angle Closure Glaucoma 
   Normal Tension Glaucoma 
   Acute Glaucoma 
   Child Glaucoma 
 
  
Progressive glaucomatous damage  
Neuropathy 
  - Vascular cause 
  - Mechanical cause 
 
Optic Nerve Fibers erosion 
Cellular anomaly 
Hereditary components Genetic mutations 
Epidemiology studies 
Association with other diseases  
Diagnosis Measurement  
IOP > Tonometer 
 
Observation  
Eye fundus > Ophthalmoscope 
Iris angle > Gonioscope  
 Digital Tonometer 
Laser Ophthalmoscope  
 
Qualitative Functionality Assessment 




Qualitative Structure Assessment 
Optic Nerve > Digital photography 
Quantitative Structure Assessment: 
Retinal Nerve Fiber Layer > 
         Scanning laser tomography  
         Scanning Polarimeter 
         Optical Coherence Tomography 








IOP lowering drugs: Beta-Blockers Combinations of eyedrops 
Neurochemistry 
Division of labour Isolated practitioners Intra-organizational collaboration 
University + Hospital 
  




   
Cross-disciplinary interaction  






 INTRA INTER 
Single-
author 
1973 16 10 45 
 (23%) (14%) (63%) 
1983 219 159 531 
 (24%) (17% (58%) 
1993 575 429 437 
 (40%) (30%) (30%) 
2003 2790 3635 586 
 (40%) (52%) (8%) 




Figure 1: Collaborative scholarly research on glaucoma by type (%) 
Legenda 
RU = RESEARCH (UNIVERSITY DEPARTMENT + RESEARCH 
LABORATORY) 
HC = GENERAL HOSPITAL + EYE CLINICS + ACADEMIC HEALTH CENTRES




  1973-2003 RU     HC     FRM     RU-HC   RU-FRM  HC-FRM  RU-HC-FR TOT TOT Cat 
Classification General Glaucoma 52 73 2 58 3 1 7 196 580 
Early    38 46 0 40 1 0 1 126 
Acute    27 61 0 28 1 0 0 117 
  Low Tension 32 57 0 48 2 0 2 141   
Epidemiology Association 176 302 2 221 2 10 8 721 1024 
  Population 51 92 3 139 6 6 6 303   
Experimental Laboratory Testing 107 142 4 135 8 15 10 421 1319 
Genetic  119 108 1 145 9 5 4 391 
Cellular Biology 106 118 11 111 12 6 8 372 
  Molecular Biology 47 38 3 41 3 1 2 135   
Diagnostics Neuropathy 124 147 3 142 6 7 3 432 2779 
Vascular 37 65 1 49 1 7 2 162 
Imaging  53 39 0 41 0 0 1 134 
Gen. Diagnostics 157 109 0 144 1 3 4 418 
Laser Diagnostics 71 88 1 65 3 7 0 235 
Ultrasound 7 21 0 8 0 0 0 36 
Nerve Fiber 40 60 0 41 2 1 1 145 
IOP      78 83 2 97 7 13 3 283 
Visual-Field 84 78 0 122 2 4 6 296 
  Eye Structure 185 229 9 201 4 6 4 638   
Therapy Laser Surgery 70 101 0 78 4 2 7 262 2130 
Iridectomy 61 96 0 61 0 3 1 222 
Trabeculectomy 123 206 0 151 5 6 3 494 
Drainage 42 85 0 67 3 3 1 201 
Drugs    172 180 28 144 29 57 29 639 
  Disease Management 82 111 4 95 5 9 6 312   
TOT 2141 2735 74 2472 119 172 119 7832 7832 
 




  1973-1990 RU     HC     FRM     RU-HC   RU-FRM  HC-FRM  RU-HC-FR TOT TOT Cat 
Classification General Glaucoma 6 7 0 9 0 0 0 22 87 
Early    7 4 0 7 0 0 1 19 
Acute    5 10 0 7 0 0 0 22 
  Low Tension 6 7 0 11 0 0 0 24   
Epidemiology Association 14 29 0 22 0 0 2 67 99 
  Population 5 12 0 15 0 0 0 32   
Experimental Laboratory Testing 11 10 0 11 0 0 1 33 100 
Genetic  10 14 0 18 0 0 0 42 
Cellular Biology 4 11 0 7 0 0 0 22 
  Molecular Biology 0 1 0 2 0 0 0 3   
Diagnostics Neuropathy 12 17 0 14 1 0 0 44 282 
Vascular 7 13 0 8 0 1 0 29 
Imaging  0 2 0 1 0 0 0 3 
Gen. Diagnostics 4 7 0 17 0 0 0 28 
Laser Diagnostics 0 2 0 0 0 0 0 2 
Ultrasound 1 2 0 2 0 0 0 5 
Nerve Fiber 3 4 0 1 0 0 0 8 
IOP      2 5 0 7 0 1 1 16 
Visual-Field 13 12 0 26 0 0 1 52 
  Eye Structure 23 42 0 28 0 1 1 95   
Therapy Laser Surgery 9 8 0 19 0 0 0 36 221 
Iridectomy 1 4 0 6 0 0 0 11 
Trabeculectomy 9 25 0 18 0 1 1 54 
Drainage 4 3 0 8 0 1 0 16 
Drugs    5 13 0 17 0 3 1 39 
  Disease Management 13 25 1 22 0 0 4 65   
  TOT 174 289 1 303 1 8 13 789 789 
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  1991-2003 RU     HC     FRM     RU-HC   RU-FRM  HC-FRM  RU-HC-FR TOT TOT Cat 
Classification General Glaucoma 46 66 2 49 3 1 7 174 493 
Early    31 42 0 33 1 0 0 107 
Acute    22 51 0 21 1 0 0 95 
  Low Tension 26 50 0 37 2 0 2 117   
Epidemiology Association 162 273 2 199 2 10 6 654 925 
  Population 46 80 3 124 6 6 6 271   
Experimental Laboratory Testing 96 132 4 124 8 15 9 388 1219 
Genetic  109 94 1 127 9 5 4 349 
Cellular Biology 102 107 11 104 12 6 8 350 
  Molecular Biology 47 37 3 39 3 1 2 132   
Diagnostics Neuropathy 112 130 3 128 5 7 3 388 2497 
Vascular 30 52 1 41 1 6 2 133 
Imaging  53 37 0 40 0 0 1 131 
Gen. Diagnostics 153 102 0 127 1 3 4 390 
Laser Diagnostics 71 86 1 65 3 7 0 233 
Ultrasound 6 19 0 6 0 0 0 31 
Nerve Fiber 37 56 0 40 2 1 1 137 
IOP      76 78 2 90 7 12 2 267 
Visual-Field 71 66 0 96 2 4 5 244 
  Eye Structure 162 187 9 173 4 5 3 543   
Therapy Laser Surgery 61 93 0 59 4 2 7 226 1909 
Iridectomy 60 92 0 55 0 3 1 211 
Trabeculectomy 114 181 0 133 5 5 2 440 
Drainage 38 82 0 59 3 2 1 185 
Drugs    167 167 28 127 29 54 28 600 
  Disease Management 69 86 3 73 5 9 2 247   
TOT 1967 2446 73 2169 118 164 106 7043 7043 
 
 




Figure 2: Correspondence Analysis 1973-1990 
 
Figure 3: Correspondence Analysis 1991-2003 
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Appendix: Topic Identifier and coding for Correspondence Analysis 
Macro-Areas Coded Topic Description 
Classification 1. General Glaucoma General essays; literature reviews 
 2. Early    Studies on Early glaucoma 
 3. Acute    Studies on Acute glaucoma 
 4. Low Tension Studies on Low-Tension glaucoma 
Epidemiology 5. Association Correlation between glaucoma and other diseases 
 6. Population Prevalence across patients by demographic group 
Experimental 7. Laboratory Testing Laboratory experiments with animals or in vitro 
 8. Genetic  Studies on hereditary glaucoma and genetics 
 9. Cellular Biology Studies on the cellular functioning of glaucoma  
 10. Molecular Biology Studies on molecular processes of glaucoma 
Diagnostics 11. Neuropathy Neuropathy (damage depends on optic nerve) 
 12. Vascular Vascular theory (IOP damages optic nerve) 
 13. Imaging  Reports on Imaging Technologies for glaucoma 
 14. General Diagnostics Reports on General Diagnostic techniques 
 15. Laser Diagnostics Reports on laser diagnostic devices for glaucoma 
 16. Ultrasound Reports on Ultrasound technology on glaucoma 
 17. Nerve Fiber Reports on Retinal Fiber Nerve Layer analysis 
 18. IOP      Reports on Intra-Ocular Pressure measurement 
 19. Visual-Field Reports on Visual Field assessment 
 20. Eye Structure Reports on observed variations of glaucomatous eye 
Therapy 21. Laser Surgery Reports on laser surgery techniques for glaucoma 
 22. Iridectomy Reports on iris incision surgery 
 23. Trabeculectomy Reports on surgical removal of trabecular meshwork 
 24. Drainage Reports on surgical insertion of drainage device 
 25. Drugs    Reports on glaucoma drug development 




                                                 
1 To fix ideas, virus theory provided the framework of reference for studies on cancer which led to the 
discovery of oncogenes (Kardinal and Yarbro, 1979); kinematics influenced the principles for artificial 
spinal disc damage (Bono and Garfin, 2004); fluid dynamics theory shaped the study of Coronary Artery 
Disease and inspired the principle of inserting artificial stents in the artery (Mina et al, 2007). 
2 This conceptual outline can be expanded to include more components as well as finer specifications of 
the existing ones; however we think that the above is inclusive enough for our purpose. 
3 Examples of indeterminacy due to lack of coordination across interdependent domains abound in studies 
of medical innovation. See e.g. Blume (1992) on the development of ultrasound diagnostics; Metcalfe et 
al (2005) on the Intra-Ocular Lens for cataract; Mina et al (2007) on the paradigm of artificial stents for 
Coronary Artery Disease; Yaqub (2009) on vaccines for polyomelitis; Morlacchi and Nelson (2010) on 
the L-VAD; Barberá et al (2010) on surgical replacement of the anatomic disc. 
4 American Health Assistance Foundation. http://www.ahaf.org/glaucoma/about/ (30 April 2010). 
5 This orientation is summarised by Weinreb (2003: 201) “With structural tests, we have to recognize that 
there is no perfect instrument.  There wasn’t one in 1994, there isn’t one in 2003, and there won’t be one 
in 2010.  Every instrument, whether objective or subjective, has advantages and disadvantages.” 
6 This screening was necessary because ISI only assigned a unique identifier to scientific papers by 
keywords after 1991. The keywords were used when they were provided in the paper; when unsure as on 
where to assign a paper, we downloaded and read the full publication and counted on the expertise of the 
various clinicians who have kindly listened and counseled us at different times in this project. 
7 Coordinates were scaled by means of canonical standardization, that is, on the basis of the relative 
frequencies (Gifi, 1981). The analysis was carried with SPSS software. 
